Amos Bar-Shalev, Director at Protalix BioTherapeutics, Inc. (PLX), sold 168 shares at $1.87 ($314) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Open-market sale of $314 PLX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.